IGHM
Immunoglobulin heavy constant mu
Also known as: IGHM_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P01871
- Gene
- IGHM
- Ensembl
- ENSG00000211899
- Chromosome
- 14
- Canonical length
- 474 aa
- Protein class
- Disease related genes, Immunoglobulin genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins
- Secretome location
- Immunoglobulin genes
- Quaternary structure
- Homohexamer
OverviewNCBI Gene
Immunoglobulins (Ig) are the antigen recognition molecules of B cells. An Ig molecule is made up of 2 identical heavy chains and 2 identical light chains (see MIM 147200) joined by disulfide bonds so that each heavy chain is linked to a light chain and the 2 heavy chains are linked together. Each Ig heavy chain has an N-terminal variable (V) region containing the antigen-binding site and a C-terminal constant (C) region, encoded by an individual C region gene, that determines the isotype of the antibody and provides effector or signaling functions. The heavy chain V region is encoded by 1 each of 3 types of genes: V genes (see MIM 147070), joining (J) genes (see MIM 147010), and diversity (D) genes (see MIM 146910). The C region genes are clustered downstream of the V region genes within the heavy chain locus on chromosome 14. The IGHM gene encodes the C region of the mu heavy chain, which defines the IgM isotype. Naive B cells express the transmembrane forms of IgM and IgD (see IGHD; MIM 1471770) on their surface. During an antibody response, activated B cells can switch to the expression of individual downstream heavy chain C region genes by a process of somatic recombination known as isotype switching. In addition, secreted Ig forms that act as antibodies can be produced by alternative RNA processing of the heavy chain C region sequences. Although the membrane forms of all Ig isotypes are monomeric, secreted IgM forms pentamers, and occasionally hexamers, in plasma (summary by Janeway et al., 2005).[supplied by OMIM, Aug 2010]
Canonical amino-acid sequenceUniProt
474 residues, UniProt reviewed canonical sequence.
>P01871|IGHM
1 GSASAPTLFP LVSCENSPSD TSSVAVGCLA QDFLPDSITF SWKYKNNSDI SSTRGFPSVL
61 RGGKYAATSQ VLLPSKDVMQ GTDEHVVCKV QHPNGNKEKN VPLPVIAELP PKVSVFVPPR
121 DGFFGNPRKS KLICQATGFS PRQIQVSWLR EGKQVGSGVT TDQVQAEAKE SGPTTYKVTS
181 TLTIKESDWL GQSMFTCRVD HRGLTFQQNA SSMCVPDQDT AIRVFAIPPS FASIFLTKST
241 KLTCLVTDLT TYDSVTISWT RQNGEAVKTH TNISESHPNA TFSAVGEASI CEDDWNSGER
301 FTCTVTHTDL PSPLKQTISR PKGVALHRPD VYLLPPAREQ LNLRESATIT CLVTGFSPAD
361 VFVQWMQRGQ PLSPEKYVTS APMPEPQAPG RYFAHSILTV SEEEWNTGET YTCVVAHEAL
421 PNRVTERTVD KSTEGEVSAD EEGFENLWAT ASTFIVLFLL SLFYSTTVTL FKVKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against IGHM can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Highest tissue expression
- 3,965 nTPM
Expression across tissuesHPA
Tissue
- spleen: 3,965 nTPM
- lymph node: 2,995 nTPM
- small intestine: 1,239 nTPM
- duodenum: 1,133 nTPM
- stomach: 499 nTPM
- tonsil: 466 nTPM
Single-cell type
- plasma cells: 486 nCPM
- b-cells: 476 nCPM
- pdcs: 59 nCPM
- thymocytes: 31 nCPM
- foveolar cells: 15 nCPM
- gastric chief cells: 14 nCPM
Immune cell
- naive B-cell: 6,750 nTPM
- memory B-cell: 4,294 nTPM
- total PBMC: 814 nTPM
- plasmacytoid DC: 347 nTPM
- neutrophil: 26 nTPM
- NK-cell: 12 nTPM
Brain region
- choroid plexus: 3.5 nTPM
- cerebral cortex: 3.1 nTPM
- medulla oblongata: 3 nTPM
- spinal cord: 1.7 nTPM
- pons: 1.1 nTPM
- thalamus: 1.1 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about IGHM.
Disease | AllUniProt
Conditions IGHM is implicated in, by any mechanism.
- Agammaglobulinemia 1, autosomal recessive (AGM1) MIM:601495
Disease | GeneticClinVar
6 pathogenic / likely-pathogenic of 10 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
Disease | ImmuneIEDB
Conditions an epitope on IGHM was assayed in.
- rheumatoid arthritis B cell
OntologyGO
Biological processes
- adaptive immune response
- antibacterial humoral response
- B cell receptor signaling pathway
- defense response to Gram-negative bacterium
- innate immune response
- pre-B cell allelic exclusion
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of IGHM in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads IGHM as an antibody target. Whether an autoantibody or antibody against IGHM could matter depends on whether native IGHM is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
IGHM is annotated at the cell surface, where native IGHM is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Source-annotated serology context
The source annotations explicitly mention antibody, autoantibody, autoantigen, or autoimmune context. This is biological context, not study-specific reactivity.
- Each Ig heavy chain has an N-terminal variable (V) region containing the antigen-binding site and a C-terminal constant (C) region, encoded by an individual C region gene, that determines the isotype of the antibody and provides effector or signaling functions.
- During an antibody response, activated B cells can switch to the expression of individual downstream heavy chain C region genes by a process of somatic recombination known as isotype switching.
- In addition, secreted Ig forms that act as antibodies can be produced by alternative RNA processing of the heavy chain C region sequences.
Loading the interactive Seroatlas protein explorer...